Zurich Cantonal Bank
SVA

Zurich Cantonal Bank’s Sinovac Biotech, Ltd SVA Stock Holding History

Zurich Cantonal Bank’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-179,899
Closed -$944K – 2483
2015
Q2 		$944K Hold
179,899
– – 0.01% 728
2015
Q1 		$892K Buy
+179,899
New +$886K 0.01% 728

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Zurich Cantonal Bank's SVA Position: Q3 2015 in Review

Zurich Cantonal Bank sold out of Sinovac Biotech, Ltd (SVA) in Q3 2015, closing a stake of 179,899 shares — an estimated $944K sold.

Zurich Cantonal Bank first reported a position in SVA in Q1 2015 and held it in 2 quarters. The position peaked at $944K in Q2 2015. 37 funds tracked by Wall St. Rank hold SVA as of Q3 2015.

  • Zurich Cantonal Bank reported no remaining Sinovac Biotech, Ltd position as of Q3 2015 after selling out during the quarter.
  • Zurich Cantonal Bank sold 179,899 Sinovac Biotech, Ltd shares in Q3 2015, an estimated $944K.
  • Zurich Cantonal Bank first reported a position in Sinovac Biotech, Ltd in Q1 2015 and held it in 2 quarters.
  • Zurich Cantonal Bank's Sinovac Biotech, Ltd position peaked at $944K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q3 2015.

Based on Zurich Cantonal Bank's 13F filing for Q3 2015, filed 10 Nov 2015.